Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria

NCT02191072 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02191072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2014
Completion date
May 31, 2016
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urticaria